Progressive multifocal leukoencephalopathy following treatment with rituximab in an HIV-negative patient with non-hodgkin lymphoma: A case report and literature review

Neuroradiology Journal

Volumn 27, Issue 6, 2014, Pages 657-664

  Felli, Valentina ^a   Di Sibio, Alessandra ^a   Anselmi, Monica ^a   Gennarelli, Antonio ^a   Sucapane, Patrizia ^c   Splendiani, Alessandra ^b   Catalucci, Alessia ^b,c   Marini, Carmine ^c   Gallucci, Massimo ^b  

^a Division of Radiology   (Italy)

^b Department of Biotechnology and Applied Clinical Sciences   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Follicular non Hodgkin lymphoma; JC virus; Progressive multifocal leukoencephalopathy; Rituximab

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; BISOPROLOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETIRACETAM; GADOLINIUM; IMMUNOGLOBULIN; MIRTAZAPINE; N ACETYLASPARTIC ACID; PREDNISOLONE; RITUXIMAB; TELMISARTAN; VINCRISTINE; VIRUS DNA; ANTINEOPLASTIC AGENT; PREDNISONE;

ADULT; ATAXIA; BABINSKI REFLEX; BASAL GANGLION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CASE REPORT; CEREBELLUM; CEREBROSPINAL FLUID ANALYSIS; CONTRAST ENHANCEMENT; ELECTROENCEPHALOGRAPHY; FECES INCONTINENCE; FEMALE; GAIT; HEMISPHERE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; JC VIRUS; LUMBAR PUNCTURE; MIDDLE AGED; MUSCLE WEAKNESS; MYOCLONUS SEIZURE; NEUROIMAGING; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSYCHOMOTOR DISORDER; REVIEW; URINE INCONTINENCE; WHITE MATTER; WHOLE BODY CT; WHOLE BODY PET; BRAIN; CHEMICALLY INDUCED; DIAGNOSTIC IMAGING; PATHOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOMA, NON-HODGKIN; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PREDNISONE; RITUXIMAB; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE;

EID: 84921637761     PISSN: 19714009     EISSN: 23851996     Source Type: Journal    
DOI: 10.15274/NRJ-2014-10087     Document Type: Review

References (19)

1. Yokoyama H, Watanabe T, Maruyama D, et al. Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature. Int J Hematol. 2008; 88: 443-447. doi: 10.1007/sl2185-008-0168-2.
2. Tavazzi E, Ferrante P, Khalili K. Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies. Clin Microbiol Infect. 2011; 17: 1776-1780. doi: 10.1111/j. 1469-0691.2011.03653.x.
3. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria. Consensus statement from the AAN Neuroinfectious Disease Section. Neurology, 2013; 80 (15): 1430-1438. doi: 10.1212AVNL.0b013e31828c2fal.
4. Lima MA. Progressive multifocal leukoencephalopathy: new concepts. Arq Neuropsiquiatr. 2013; 71 (9B): 699-702. doi: 10.1590/0004-282X20130154.
5. Berger JR, Houff SA, Major EO. Monoclonal antibodies and progressive multifocal leukoencephalopathy. MAbs. 2009; 1 (6): 583-589. doi: 10.4161/mabs.1.6.9884.
6. Chakraborty S, Tarantolo SR, Treves J, et al. Progressive multifocal leukoencephalopathy in a HIV-negative patient with small lymphocytic leukemia following treatment with rituximab. Case Rep Oncol. 2011; 4 (1): 136-142. doi: 10.1159/000326851.
7. Khoury S, Shapira S, Zilberman T, et al. Progressive multifocal leukoencephalopathy in an HIV-Negative Patient following treatment with rituximab. Isr Med Assoc J. 2013; 15 (6): 321-322.
8. Johansen KK, Torp SH, Rydland J, et al. Progressive multifocal leukoencephalopathy in an immunocompetent patient? Case Rep Neurol. 2013; 5 (3): 149-154. doi: 10.1159/000354828.
9. Gasnault J, Kahraman M, de Goer de Hervé MG, et al. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS. 2003; 17 (10): 1443-1449. doi: 10.1097/00002030-200307040-00004.
10. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from research on adverse drug events and report project. Blood. 2009; 113 (20): 4834-4840. doi: 10.1182/ blood-2008-10-186999.
11. Sikkema T, Schuiling WJ, Hoogendoorn M. Progressive multifocal leukoencephalopathy during treatment with rituximab and CHOP chemotherapy in a patient with a diffuse large B-cell lymphoma. BMJ Case Rep. 2013; doi: 10.1136/bcr-2012-008142.
12. Aksoy S, Harputluoglu H, Kilickap S, et al. Rituxi-mab-related viral infections in lymphoma patients. Leuk Lymphoma. 2007; 48 (7): 1307-1312. doi: 10.1080/10428190701411441.
13. Weber F, Goldmann C, Krämer M, et al. Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Ann Neurol. 2001; 49 (5): 636-642. doi: 10.1002/ana.l004.
14. Berger JR, Major EO. Progressive multifocal leukoencephalopathy. Semin Neurol. 1999; 19: 193-200. doi: 10.1055/S-2008-1040837.
15. Fong IW, Britton CB, Luinstra KE, et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol. 1995; 33 (2): 484-486.
16. Tuccori M, Focosi D, Blandizzi C, et al. Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy. Oncologist. 2010, 15 (11): 1214-1219. doi: 10.1634/theoncologist.2010-0098.
17. Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases, evolving role of biologic therapies. Arthritis Rheum. 2012; 64 (9): 3043-3051. doi: 10.1002/art.34468.
18. Lenkinski RE. MR Spectroscopy. In Baert AL, Sartor K. MR Imaging in white matter disease of the brain and the spinal cord. Berlin: Springer; 2005. pp. 115-127.
19. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology. 1997; 48 (4): 836-845. doi: 10.1212/WNL.48.4.836.